Synthesis and Anti-Hepatitis B Virus Activity of a Novel Class of Thiazolylbenzimidazole Derivatives
β Scribed by Yu Luo; Jia-Ping Yao; Li Yang; Chun-Lan Feng; Wei Tang; Gui-Feng Wang; Jian-Pin Zuo; Wei Lu
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 150 KB
- Volume
- 344
- Category
- Article
- ISSN
- 0365-6233
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Recently, heterocyclic benzimidazole derivatives have been investigated and validated as a promising class of antiviral agents. In this paper, a series of novel thiazolylbenzimidazole derivatives was synthesized and evaluated for their antiβhepatitis B virus (HBV) activity and cytotoxicity on the HepG2.2.15 cell line. Afterwards, the preliminary structureβactivity relationship (SAR) was discussed. Compound 8b, with IC~50~β=β1.1βΒ΅M and SIβ>β90.9, was the most promising compound and could be selected as a benchmark compound for further investigation.
π SIMILAR VOLUMES
The role of reactive oxygen species in inflammatory processes has been well documented, while several antioxidant compounds have been shown to exhibit anti-inflammatory activity. We designed novel compounds as potential agents that combine enhanced antioxidant and anti-inflammatory activities. Deriv
HBsAg is the most important serological marker for acute or chronic hepatitis B. Nevertheless, there are reports of HBsAg-negative virus carriers, either with anti-HBc as the only marker for hepatitis B virus (HBV) infection or even positive for anti-HBs and anti-HBc. We report isolates from a patie